Recombinant fusion protein of coronavirus ORF7a(YP_009724395.1).
Conjugation:
Unconjugated
Alternative Names:
sars-cov-2
Plays a role as antagonist of host tetherin (BST2, disrupting its antiviral effect. Acts by binding to BST2 thereby interfering with its glycosylation. May suppress small interfering RNA (siRNA. May bind to host ITGAL, thereby playing a role in attachment or modulation of leukocytes.
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
Form:
1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2
Application Dilute:
WB,1:500 - 1:2000
Application Notes:
Unmodification
* VAT and and shipping costs not included. Errors and price changes excepted
